Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany

Seasonal influenza causes many cases and related deaths in Europe annually, despite ongoing vaccination programs for older adults and people at high-risk of complications. Children have the highest risk of infection and play a key role in disease transmission. Our cost-utility analysis, based on a d...

Description complète

Détails bibliographiques

Auteurs principaux:	Daniel Molnar, Anastassia Anastassopoulou, Barbara Poulsen Nautrup, Ruprecht Schmidt-Ott, Martin Eichner, Markus Schwehm, Gael Dos Santos, Bernhard Ultsch, Rafik Bekkat-Berkani, Alfred von Krempelhuber, Ilse Van Vlaenderen, Laure-Anne Van Bellinghen
Format:	Artigo
Langue:	Inglês
Publié:	Taylor & Francis Group 2022-11-01
Collection:	Human Vaccines & Immunotherapeutics
Sujets:	children economic model germany quadrivalent influenza vaccine seasonal influenza uptake
Accès en ligne:	http://dx.doi.org/10.1080/21645515.2022.2058304
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!